{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T10:16:31Z","timestamp":1775729791822,"version":"3.50.1"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T00:00:00Z","timestamp":1765497600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug and Alcohol Dependence Reports"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.dadr.2025.100404","type":"journal-article","created":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T17:03:01Z","timestamp":1765904581000},"page":"100404","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Characteristics and comorbidities of patients on opioid agonist therapy in Switzerland: A descriptive analysis of the nationwide SAMMSU cohort"],"prefix":"10.1016","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6234-048X","authenticated-orcid":false,"given":"Michael","family":"L\u00fctolf","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1997-7335","authenticated-orcid":false,"given":"Andrea","family":"Bregenzer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0436-8895","authenticated-orcid":false,"given":"Philip","family":"Bruggmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1968-9405","authenticated-orcid":false,"given":"Alberto","family":"Moriggia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-7569-3053","authenticated-orcid":false,"given":"Claude","family":"Scheidegger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-4261-8644","authenticated-orcid":false,"given":"Katharina","family":"Hensel-Koch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2437-5627","authenticated-orcid":false,"given":"Erika Castro","family":"Bat\u00e4njer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1357-0347","authenticated-orcid":false,"given":"Maria Christine","family":"Thurnheer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pascale","family":"Della Santa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4422-7250","authenticated-orcid":false,"given":"Oliver","family":"Senn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1564-5296","authenticated-orcid":false,"given":"Thomas","family":"Grischott","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.dadr.2025.100404_bib1","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1007\/s00228-023-03559-4","article-title":"Prevalence, trends, and individual patterns of long-term antidepressant medication use in the adult Swiss general population","volume":"79","author":"Amrein","year":"2023","journal-title":"Eur. J. Clin. Pharm."},{"issue":"2","key":"10.1016\/j.dadr.2025.100404_bib2","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1017\/S1121189X00006278","article-title":"Prevalence of mental disorders in the Zurich Cohort Study: a twenty year prospective study","volume":"14","author":"Angst","year":"2005","journal-title":"Epidemiol. Psychiatr. Sci."},{"issue":"4","key":"10.1016\/j.dadr.2025.100404_bib3","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1111\/acps.13088","article-title":"Reduction in mortality risk with opioid agonist therapy: a systematic review and meta-analysis","volume":"140","author":"Bahji","year":"2019","journal-title":"Acta Psychiatr. Scand."},{"issue":"1","key":"10.1016\/j.dadr.2025.100404_bib4","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1186\/s12913-019-4282-z","article-title":"Mortality and causes of death among patients with opioid use disorder receiving opioid agonist treatment: a national register study","volume":"19","author":"Bech","year":"2019","journal-title":"BMC Health Serv. Res"},{"key":"10.1016\/j.dadr.2025.100404_bib5","doi-asserted-by":"crossref","first-page":"w20460","DOI":"10.4414\/smw.2021.20460","article-title":"Hepatitis C virus elimination in Swiss opioid agonist therapy programmes - the SAMMSU cohort","volume":"151","author":"Bregenzer","year":"2021","journal-title":"Swiss Med. Wkly"},{"issue":"4950","key":"10.1016\/j.dadr.2025.100404_bib6","doi-asserted-by":"crossref","first-page":"40009","DOI":"10.57187\/smw.2022.40009","article-title":"HCV elimination in a Swiss opioid agonist therapy programme - a cohort study","volume":"152","author":"Bregenzer","year":"2022","journal-title":"Swiss Med. Wkly"},{"key":"10.1016\/j.dadr.2025.100404_bib7","author":"Bundesamt f\u00fcr Gesundheit","year":"2013","journal-title":"Substit. \u00fctzte Behandl. bei Opioidabh\u00e4ngigkeit Revis."},{"key":"10.1016\/j.dadr.2025.100404_bib8","series-title":"Sexuell \u00fcbertragene Infektionen und Hepatitis B\/C in der Schweiz und Liechtenstein im Jahr 2023: eine epidemiologische Beurteilung","author":"Bundesamt f\u00fcr Gesundheit","year":"2024"},{"key":"10.1016\/j.dadr.2025.100404_bib9","series-title":"Ergebnisse der Schweizerischen Gesundheitsbefragung","author":"Bundesamt f\u00fcr Statistik","year":"2023"},{"issue":"10208","key":"10.1016\/j.dadr.2025.100404_bib10","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1016\/S0140-6736(19)32229-9","article-title":"Global patterns of opioid use and dependence: harms to populations, interventions, and future action","volume":"394","author":"Degenhardt","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.dadr.2025.100404_bib11","unstructured":"European Union Drugs Agency. 2025. Opioid agonist treatment \u2013 the current situation in Europe (European Drug Report 2025). \u3008https:\/\/www.euda.europa.eu\/publications\/european-drug-report\/2025\/opioid-agonist-treatment_en\u3009"},{"key":"10.1016\/j.dadr.2025.100404_bib12","doi-asserted-by":"crossref","unstructured":"Gmel, G., & Labhart, F. 2023. Heroingest\u00fctzte\/diacetylmorphingest\u00fctzte Behandlung in der Schweiz \u2013 Resultate der Erhebung 2022. https:\/\/doi.org\/10.58758\/rech157","DOI":"10.58758\/rech157"},{"issue":"3","key":"10.1016\/j.dadr.2025.100404_bib13","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0740-5472(03)00130-2","article-title":"Overview of 5-year followup outcomes in the drug abuse treatment outcome studies (DATOS)","volume":"25","author":"Hubbard","year":"2003","journal-title":"J. Subst. Abus. Treat."},{"issue":"18","key":"10.1016\/j.dadr.2025.100404_bib14","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1097\/QAD.0000000000000878","article-title":"The HIV care cascade in Switzerland: reaching the UNAIDS\/WHO targets for patients diagnosed with HIV","volume":"29","author":"Kohler","year":"2015","journal-title":"AIDS"},{"key":"10.1016\/j.dadr.2025.100404_bib15","author":"Labhart","year":"2024","journal-title":"Natl. Stat. der OpioidAgonistenTher."},{"key":"10.1016\/j.dadr.2025.100404_bib16","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.2147\/NDT.S290104","article-title":"Benzodiazepine and Z-Drug Use in Switzerland: Prevalence, Prescription Patterns and Association with Adverse Healthcare Outcomes","volume":"17","author":"Landolt","year":"2021","journal-title":"Neuropsychiatr. Dis. Treat."},{"issue":"1","key":"10.1016\/j.dadr.2025.100404_bib17","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/s13011-020-00311-4","article-title":"Large and non-specific somatic disease burdens among ageing, long-term opioid maintenance treatment patients","volume":"15","author":"Medved","year":"2020","journal-title":"Subst. Abus. Treat. Prev. Policy"},{"key":"10.1016\/j.dadr.2025.100404_bib18","unstructured":"Nationale OAT-Statistik. (2023). J\u00e4hrliche Statistik Schweiz - 2023. Retrieved 10.07.2025 from https:\/\/www.tao-oat.ch\/de\/jahrliche_statistik.html&year=2023&canton=ch."},{"issue":"2","key":"10.1016\/j.dadr.2025.100404_bib19","first-page":"93","article-title":"The Societal Costs of Schizophrenia in Switzerland","volume":"18","author":"Pletscher","year":"2015","journal-title":"J. Ment. Health Policy Econ."},{"issue":"2","key":"10.1016\/j.dadr.2025.100404_bib20","doi-asserted-by":"crossref","DOI":"10.18278\/ijc.10.2.12","article-title":"The normalization of swiss drug policies","volume":"10","author":"Pollien","year":"2023","journal-title":"Int. J. Criminol."},{"key":"10.1016\/j.dadr.2025.100404_bib21","article-title":"Opioid agonist treatment. Guiding principles for legislation and regulations","author":"Pompidou Group","year":"2017","journal-title":"Expert Group Regul. Framew. Treat. opioid Depend. Syndr. Prescr. opioid agonist Med."},{"issue":"4","key":"10.1016\/j.dadr.2025.100404_bib22","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1093\/ije\/dym096","article-title":"Cohort Profile: the Swiss Hepatitis C Cohort Study (SCCS)","volume":"36","author":"Prasad","year":"2007","journal-title":"Int J. Epidemiol."},{"key":"10.1016\/j.dadr.2025.100404_bib23","article-title":"R: a language and environment for statistical computing","author":"R Core Team","year":"2024","journal-title":"R. Found. Stat. Comput."},{"key":"10.1016\/j.dadr.2025.100404_bib24","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.832994","article-title":"Prescription rates, polypharmacy and prescriber variability in Swiss general practice\u2014a cross-sectional database study","volume":"13","author":"Rachamin","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.dadr.2025.100404_bib25","author":"SAMMSU","year":"2024","journal-title":"Swiss Assoc. Med. Manag. Subst. Users"},{"issue":"9","key":"10.1016\/j.dadr.2025.100404_bib26","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1001\/jamapsychiatry.2021.0976","article-title":"Association of opioid agonist treatment with all-cause mortality and specific causes of death among people with opioid dependence: a systematic review and meta-analysis","volume":"78","author":"Santo","year":"2021","journal-title":"JAMA Psychiatry"},{"issue":"1","key":"10.1016\/j.dadr.2025.100404_bib27","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1093\/ije\/dyab141","article-title":"Cohort profile update: the Swiss HIV Cohort Study (SHCS)","volume":"51","author":"Scherrer","year":"2022","journal-title":"Int J. Epidemiol."},{"key":"10.1016\/j.dadr.2025.100404_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2023.111036","article-title":"Opioid agonist treatment in transition: a cross-country comparison between Austria, Germany and Switzerland","volume":"254","author":"Schwarz","year":"2024","journal-title":"Drug Alcohol Depend."},{"issue":"3","key":"10.1016\/j.dadr.2025.100404_bib29","first-page":"284","article-title":"Age-dependent risk and lifetime risk of developing cancer in Switzerland","volume":"37","author":"Six","year":"2017","journal-title":"Schweiz. KrebsBull. = Bull. Suisse du Cancer"},{"issue":"1","key":"10.1016\/j.dadr.2025.100404_bib30","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/j.1360-0443.2009.02741.x","article-title":"Heroin-assisted treatment in Switzerland: a case study in policy change","volume":"105","author":"Uchtenhagen","year":"2010","journal-title":"Addiction"},{"issue":"3","key":"10.1016\/j.dadr.2025.100404_bib31","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/hiv.12184","article-title":"Influence of noninjecting and injecting drug use on mortality, retention in the cohort, and antiretroviral therapy, in participants in the Swiss HIV Cohort Study","volume":"16","author":"Weber","year":"2015","journal-title":"HIV Med"},{"issue":"43","key":"10.1016\/j.dadr.2025.100404_bib32","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.21105\/joss.01686","article-title":"Welcome to the Tidyverse","volume":"4","author":"Wickham","year":"2019","journal-title":"J. Open Source Softw."},{"key":"10.1016\/j.dadr.2025.100404_bib33","series-title":"Guidelines for the psychosocially assisted pharmacological treatment of opioid dependence","author":"World Health Organization","year":"2009"},{"key":"10.1016\/j.dadr.2025.100404_bib34","series-title":"Opioid overdose","author":"World Health Organization","year":"2023"},{"key":"10.1016\/j.dadr.2025.100404_bib35","unstructured":"Zahnd, C., Brezzi, M., Bertisch, B., Giudici, F., & Keiser, O. 2017. Analyse de Situation des H\u00e9patites B et C en Suisse: Rapport int\u00e9gral - Rapport Int\u00e9gral (mit Zusammenfassung in deutscher Sprache). \u3008https:\/\/backend.bag.admin.ch\/fileservice\/sdweb-docs-prod-bagadminch-files\/files\/2025\/03\/18\/aae734b1-4982-4687-a846-ef7f0077d4df.pdf\u3009"}],"container-title":["Drug and Alcohol Dependence Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772724625000873?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772724625000873?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T19:02:44Z","timestamp":1773255764000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772724625000873"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":35,"alternative-id":["S2772724625000873"],"URL":"https:\/\/doi.org\/10.1016\/j.dadr.2025.100404","relation":{},"ISSN":["2772-7246"],"issn-type":[{"value":"2772-7246","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Characteristics and comorbidities of patients on opioid agonist therapy in Switzerland: A descriptive analysis of the nationwide SAMMSU cohort","name":"articletitle","label":"Article Title"},{"value":"Drug and Alcohol Dependence Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dadr.2025.100404","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"100404"}}